154 related articles for article (PubMed ID: 10516638)
1. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle.
Holland M; John Challiss RA; Standen NB; Boyle JP
Br J Pharmacol; 1999 Oct; 128(3):597-604. PubMed ID: 10516638
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
Chataigneau T; Félétou M; Thollon C; Villeneuve N; Vilaine JP; Duhault J; Vanhoutte PM
Br J Pharmacol; 1998 Mar; 123(5):968-74. PubMed ID: 9535027
[TBL] [Abstract][Full Text] [Related]
3. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.
Felder CC; Joyce KE; Briley EM; Glass M; Mackie KP; Fahey KJ; Cullinan GJ; Hunden DC; Johnson DW; Chaney MO; Koppel GA; Brownstein M
J Pharmacol Exp Ther; 1998 Jan; 284(1):291-7. PubMed ID: 9435190
[TBL] [Abstract][Full Text] [Related]
4. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
Rinaldi-Carmona M; Barth F; Millan J; Derocq JM; Casellas P; Congy C; Oustric D; Sarran M; Bouaboula M; Calandra B; Portier M; Shire D; Brelière JC; Le Fur GL
J Pharmacol Exp Ther; 1998 Feb; 284(2):644-50. PubMed ID: 9454810
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
[TBL] [Abstract][Full Text] [Related]
6. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.
Glass M; Felder CC
J Neurosci; 1997 Jul; 17(14):5327-33. PubMed ID: 9204917
[TBL] [Abstract][Full Text] [Related]
7. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
8. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).
Hillard CJ; Manna S; Greenberg MJ; DiCamelli R; Ross RA; Stevenson LA; Murphy V; Pertwee RG; Campbell WB
J Pharmacol Exp Ther; 1999 Jun; 289(3):1427-33. PubMed ID: 10336536
[TBL] [Abstract][Full Text] [Related]
10. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the vasorelaxation to methanandamide in rat gastric arteries.
Breyne J; Van de Voorde J; Vanheel B
Can J Physiol Pharmacol; 2006 Nov; 84(11):1121-32. PubMed ID: 17218976
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of cyclic AMP-mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat.
Priest RM; Hucks D; Ward JP
Br J Pharmacol; 1999 May; 127(1):291-9. PubMed ID: 10369485
[TBL] [Abstract][Full Text] [Related]
13. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of adenylate cyclase attenuates adenosine receptor-mediated relaxation in coronary artery.
Sabouni MH; Cushing DJ; Makujina SR; Mustafa SJ
J Pharmacol Exp Ther; 1991 Nov; 259(2):508-12. PubMed ID: 1658301
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
16. SR144528 as inverse agonist of CB2 cannabinoid receptor.
Rhee MH; Kim SK
J Vet Sci; 2002 Sep; 3(3):179-84. PubMed ID: 12514329
[TBL] [Abstract][Full Text] [Related]
17. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
Portier M; Rinaldi-Carmona M; Pecceu F; Combes T; Poinot-Chazel C; Calandra B; Barth F; le Fur G; Casellas P
J Pharmacol Exp Ther; 1999 Feb; 288(2):582-9. PubMed ID: 9918562
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.
Begg M; Baydoun A; Parsons ME; Molleman A
J Physiol; 2001 Feb; 531(Pt 1):95-104. PubMed ID: 11179394
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of cannabinoid receptors.
Howlett AC
Annu Rev Pharmacol Toxicol; 1995; 35():607-34. PubMed ID: 7598509
[TBL] [Abstract][Full Text] [Related]
20. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]